Insights From Authors & Announcements
-
Metformin & Leucine Prevent Cellular Senescence & Proteostasis Disruption
PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 15, Issue 6, entitled, “Cellular senescence and disrupted proteostasis induced by myotube atrophy are prevented with low-dose metformin and leucine cocktail.”
-
Senescence and Extracellular Vesicles: Novel Partners in Vascular Amyloidosis
PRESS RELEASE: A new editorial paper was published in Aging’s Volume 15, Issue 5, entitled, “Senescence and extracellular vesicles: novel partners in vascular amyloidosis.” … continue reading
-
Aging | Parsing Chronological and Biological Age Effects on Vaccine Responses
PRESS RELEASE: Researchers Chris P. Verschoor and George A. Kuchel from Health Sciences North Research Institute published a new editorial in Aging, entitled, “Parsing chronological and biological age effects on vaccine responses.” … continue reading
-
Behind the Study: Aging and Memory Altered in Neurons or Glia of Flies
Ariel K. Frame from Western University discusses a research paper he co-authored that was published by Aging (Aging-US) in Volume 15, Issue 4, entitled, “Aging and memory are altered by genetically manipulating lactate dehydrogenase in the neurons or glia of flies.” … continue reading
Aging: Volume 15, Issue 6
-
Cellular senescence and disrupted proteostasis induced by myotube atrophy are prevented with low-dose metformin and leucine cocktail
Aging coincides with the accumulation of senescent cells within skeletal muscle that produce inflammatory products, known as the senescence-associated secretory phenotype, but the relationship of senescent cells to muscle atrophy is unclear…
Aging News & Blogs
ABOUT AGING-US.NET
Aging-US.net features interviews and testimonials from the distinguished network of authors who continue to publish their research with Aging (Aging-US)—a twice-monthly, traditional, peer-reviewed journal with open access, covering all areas of research on aging, including age-related diseases, such as cancer.
The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases and prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.
Impact Journals, the publisher of Aging (Aging-US), meets the standards of the Wellcome Trust Publisher Requirements and was included in the Wellcome Trust List of Compliant Publishers. Read about our rigorous Scientific Integrity Process.
To learn more, please visit Aging-US.com and connect with us:
Facebook | Twitter | LinkedIn | YouTube | Instagram | Pinterest | SoundCloud
